References

1. Velazquez EF, Soskin A, Bock A, Codas R, Barreto JE, Cubilla AL. Positive resection margins in partial penectomies: sites of involvement and proposal of local routes of spread of penile squamous cell carcinoma. Am J Surg Pathol. 2004;28:384-389.

2. Rippentrop JM, Joslyn SA, Konety BR. Squamous cell carcinoma of the penis: evaluation of data from the surveillance, epidemiology, and end results program. Cancer. 2004;101(6): 1357-1363.

3. Hakenberg OW, Wirth MP. Issues in the treatment of penile carcinoma. A short review. Urol Int. 1999;62(4):229-233.

4. Ornellas AA, Seixas AL, Marota A, et al. Surgical treatment of invasive squamous cell carcinoma of the penis: retrospective analysis of 350 cases. J Urol. 1994;151(5):1244-1249.

5. Horenblas S, van Tinteren H, Delemarre JF, et al. Squamous cell carcinoma of the penis. III. Treatment of regional lymph nodes. J Urol. 1993;149(3):492-497.

6. Bouchot O, Auvigne J, Peuvrel P, et al. Management of regional lymph nodes in carcinoma of the penis. Eur Urol. 1989;16(6):410-415.

7. Pizzocaro G, Piva L, Bandieramonte G, et al. Up-to-date management of carcinoma of the penis. Eur Urol. 1997;32(1):5-15.

8. Ficarra V, Akduman B., Bouchot O., Palou J., Tobias-Machado M. Prognostic factors in penile cancer. In: Pompeo AC, Heyns CF, Abrams P, eds. Penile Cancer. International Consultation on Penile Cancer, Edition 2009.

9. Villavicencio H, Rubio-Briones J, Regalado R, et al. Grade, local stage and growth pattern as prognostic factors in carcinoma of the penis. Eur Urol. 1997;32(4):442-447.

10. Bezerra AL, Lopes A, Santiago GH, et al. Human papillomavirus as a prognostic factor in carcinoma of the penis: analysis of 82 patients treated with amputation and bilateral lymph-adenectomy. Cancer. 2001;91(12):2315-2321.

11. Novara G, Galfano A, De Marco V, et al. Prognostic factors in squamous cell carcinoma of the penis. Nat Clin Pract Urol. 2007;4(3):140-146.

12. Pandey D, Mahajan V, Kannan RR. Prognostic factors in node-positive carcinoma of the penis. J Surg Oncol. 2006;93(2):133-138.

13. Srinivas V, Morse MJ, Herr HW, et al. Penile cancer: relation of extent of nodal metastasis to survival. J Urol. 1987;137(5):880-882.

14. Ravi R. Correlation between the extent of nodal involvement and survival following groin dissection for carcinoma of the penis. Br J Urol. 1993;72(5 Pt 2):817-819.

15. Leijte JA, Gallee M, Antonini N, Horenblas S. Evaluation of current TNM classification of penile carcinoma. J Urol. 2008;180:933-938.

16. Misra S, Chaturvedi A, Misra NC. Penile carcinoma: a challenge for the developing world. Lancet Oncol. 2004;5(4):240-247.

17. Ficarra V, Zattoni F, Cunico SC, et al. Gruppo Uro-Oncologico del Nord Est (Northeast Uro-Oncological Group) Penile Cancer Project. Lymphatic and vascular embolizations are independent predictive variables of inguinal lymph node involvement in patients with squamous cell carcinoma of the penis: Gruppo Uro-Oncologico del Nord Est (Northeast Uro-Oncological Group) Penile Cancer data base data. Cancer. 2005;103(12):2507-2516.

18. Leijte JA, Kirrander P, Antonini N, et al. Recurrence patterns of squamous cell carcinoma of the penis: recommendations for follow-up based on a two-centre analysis of 700 patients. Eur Urol. 2008;54(1):161-168.

19. Horenblas S. Lymphadenectomy for squamous cell carcinoma of the penis. Part 2: the role and technique of lymph node dissection. BJUInt. 2001;88(5):473-483.

20. Lopes A, Bezerra AL, Pinto CA, et al. p53 as a new prognostic factor for lymph node metastasis in penile carcinoma: analysis of 82 patients treated with amputation and bilateral lymph-adenectomy. J Urol. 2002;168(1):81-86.

21. Guimaräes GC, Lopes A, Campos RS, et al. Front pattern of invasion in squamous cell carcinoma of the penis: new prognostic factor for predicting risk of lymph node metastases. Urology. 2006;68(1):148-153.

22. Campos RS, Lopes A, Guimaräes GC, et al. E-cadherin, MMP-2, and MMP-9 as prognostic markers in penile cancer: analysis of 125 patients. Urology. 2006;67(4):797-802.

23. Lopes A, Hidalgo GS, Kowalski LP, et al. Prognostic factors in carcinoma of the penis: multivariate analysis of 145 patients treated with amputation and lymphadenectomy. J Urol. 1996;156(5): 1637-1642.

24. Lont AP, Kroon BK, Horenblas S, et al. Presence of high-risk human papillomavirus DNA in penile carcinoma predicts favorable outcome in survival. Int J Cancer. 2006;119(5):1078-1081.

25. Guimaräes GC, Leal ML, Campos RS, et al. Do proliferating cell nuclear antigen and MIB-1/ Ki-67 have prognostic value in penile squamous cell carcinoma? Urology. 2007;70(1):137-142.

26. Harmer MH. Penis (ICD-0187). In: TNM Classification ofMalignant Tumours, 3rd ed. Geneva: International Union Against Cancer, pp. 126, 1978.

27. Horenblas S, van Tinteren H. Squamous cell carcinoma of the penis. IV. Prognostic factors of survival: analysis of tumor, nodes and metastasis classification system. J Urol. 1994;151(5): 1239-1243.

28. Guimaraes GC, Cunha IW, Soares FA, et al. Penile squamous cell carcinoma clinicopathological features, nodal metastasis and outcome in 333 cases. J Urol. 2009;182:528-534.

29. Dai B, Ye DW, Kong YY, et al. Predicting regional lymph node metastasis in Chinese patients with penile squamous cell carcinoma: the role of histopathological classification, tumor stage and depth of invasion. J Urol. 2006;176(4 Pt 1):1431-1435.

30. Broders AC. Squamous-cell epithelioma of the skin: a study of256 cases. Ann Surg. 1921;73(2): 141-160.

31. Slaton JW, Morgenstern N, Levy DA, et al. Tumor stage, vascular invasion and the percentage of poorly differentiated cancer: independent prognosticators for inguinal lymph node metastasis in penile squamous cancer. J Urol. 2001;165(4):1138-1142.

32. Ficarra V, Maffei N, Piacentini I, et al. Local treatment of penile squamous cell carcinoma. Urol Int. 2002;69(3): 169-173.

33. Chaux A, Caballero C, Soares F, Guimaraes GC, Cunha IW, Reuter V, Barreto J, Rodriguez I, Cubilla AL. The prognostic index: a useful pathologic guide for prediction of nodal metastases and survival in penile squamous cell carcinoma. Am J Surg Pathol. 2009 Apr 18.

34. Cubilla AL, Barreto J, Caballero C, et al. Pathologic features of epidermoid carcinoma of the penis. A prospective study of 66 cases. Am J Surg Pathol. 1993;17(8):753-763.

35. Anneroth G, Batsakis J, Luna M. Review of the literature and a recommended system of malignancy grading in oral squamous cell carcinomas. Scand J Dent Res. 1987;95(3):229-249.

36. Bryne M, Koppang HS, Lilleng R, et al. New malignancy grading is a better prognostic indicator than Broders' grading in oral squamous cell carcinomas. J Oral Pathol Med. 1989;18(8): 432-437.

37. Wiener JS, Effert PJ, Humphrey PA, et al. Prevalence of human papillomavirus types 16 and 18 in squamous-cell carcinoma of the penis: a retrospective analysis of primary and metastatic lesions by differential polymerase chain reaction. Int J Cancer. 1992;50(5):694-701.

38. Minhas S, Manseck A., Hegarty P., Watya S. Prevention and premalignant conditions. In: Pompeo AC, Heyns CF, Abrams P, Eds. Penile Cancer. International Consultation on Penile Cancer, Edition 2009.

39. Protzel C, Knoedel J, Zimmermann U, et al. Expression of proliferation marker Ki67 correlates to occurrence of metastasis and prognosis, histological subtypes and HPV DNA detection in penile carcinomas. Histol Histopathol. 2007;22(11):1197-1204.

40. Solsona E, Iborra I, Ricos JV, et al. Corpus cavernosum invasion and tumor grade in the prediction of lymph node condition in penile carcinoma. Eur Urol. 1992;22(2):115-118.

41. Solsona E, Iborra I, Rubio J, et al. Prospective validation of the association of local tumor stage and grade as a predictive factor for occult lymph node micrometastasis in patients with penile carcinoma and clinically negative inguinal lymph nodes. J Urol. 2001;165(5):1506-1509.

42. Solsona E, Algaba F, Horenblas S, et al. European Association of Urology. EAU Guidelines on Penile Cancer. Eur Urol. 2004;46(1):1-8.

43. Novara G, Artibani W, Cunico SC, et al. GUONE Penile Cancer Project. How accurately do Solsona and European Association of Urology risk groups predict for risk of lymph node metastases in patients with squamous cell carcinoma of the penis? Urology. 2008;71(2): 328-333.

44. Ficarra V, Zattoni F, Artibani W, G.U.O.N.E. Penile Cancer Project Members, et al. Nomogram predictive of pathological inguinal lymph node involvement in patients with squamous cell carcinoma of the penis. J Urol. 2006;175(5):1700-1704.

45. Kattan MW, Ficarra V, Artibani W, et al. GUONE Penile Cancer Project Members. Nomogram predictive of cancer specific survival in patients undergoing partial or total amputation for squamous cell carcinoma of the penis. J Urol. 2006;175(6):2103-2108.

46. Bhagat SK, Gopolakrishnan G, Kekre NS, Chacko NK, Manipadam MT, Samuel P. Factors predicting inguinal node metastasis in squamous cell cancer of penis. World J Urol. 2009 Jun 2.

47. Heyns C, Fleshner N, Sangar V, Schlenker B, Thyavihally Y, van Poppel H. Management of the lymph nodes in penile cancer. In: Pompeo AC, Heyns CF, Abrams P, eds. Penile Cancer. International Consultation on Penile Cancer, Edition 2009.

48. Zhu Y, Zhou XY, Yao XD, et al. The prognostic significance of p53, Ki-67, epithelial Cadherin and matrix metalloproteinase-9 in penile squamous cell carcinoma treated with surgery. BJU Int. 2007;100(1):204-208.

49. Behrens J, Mareel MM, Van Roy FM, et al. Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J Cell Biol. 1989;108(6):2435-2447.

50. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2002;2(3):161-174.

51. Berdjis N, Meye A, Nippgen J, et al. Expression of Ki-67 in squamous cell carcinoma of the penis. BJU Int. 2005;96(1):146-148.

52. Dong JT, Lamb PW, Rinker-Schaeffer CW, et al. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science. 1995;268(5212):884-886.

53. Son BH, Choi JS, Lee JH. Prognostic values of KAI1 and survivin expression in an infiltrating ductal carcinoma of the breast. Pathology. 2005;37(2):131-136.

54. Yang X, Wei L, Tang C, et al. KAI1 protein is down-regulated during the progression of human breast cancer. Clin Cancer Res. 2000;6(9):3424-3429.

55. Zheng H, Tsuneyama K, Cheng C, et al. Expression of KAI1 and tenascin, and microvessel density are closely correlated with liver metastasis of gastrointestinal adenocarcinoma. J Clin Pathol. 2007;60(1):50-56.

56. Protzel C, Kakies C, Kleist B, et al. Down-regulation of the metastasis suppressor protein KAI1/CD82 correlates with occurrence of metastasis, prognosis and presence of HPV DNA in human penile squamous cell carcinoma. Virchows Arch. 2008;452(4):369-375.

57. Bhagat SK, Gopolakrishnan G, Kekre NS, Chacko NK, Manipadam MT, Samuel P. Factors predicting inguinal node metastasis in squamous cell cancer of penis. World J Urol. 2010;28(1):93-98.

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook


Post a comment